InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,780.05
(
-0.21%
)
US TECH 100
19,731.60
(
0.03%
)
Dow Jones
42,454.12
(
-0.14%
)
Brent Oil
78.71
(
-0.45%
)
Bitcoin
60,103.00
(
-0.28%
)
Post# of 19309
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

floblu14

Send PM Follow Ignore
Followers 22
Posts 3716
Boards Moderated 0
Alias Born 07/20/2006

floblu14

Re: None

Friday, 09/28/2007 8:50:28 AM

Friday, September 28, 2007 8:50:28 AM

Post# of 19309
>Gelineau said SAFC also is negotiating with Framingham, Mass.-based GTC Biotherapeutics Inc., a biotech company that developed ATryn, an anti-clotting agent produced in the milk of genetically modified goats. ATryn has been approved for use by the European Commission and is in late-stage human clinical trials in the United States.<

http://www.stltoday.com/stltoday/business/stories.nsf/manufacturingtechnology/story/7E5FBCCD56DBF22E...
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up